Menu

Choosing Immunotherapy

January 10, 2019 | Video Library | Clinical Pearls, Immunotherapy
Featuring:
Morganna Freeman, DO, FACP
Morganna Freeman, DO, FACP
Assistant Clinical Professor & Medical Director of Community Clinical Research, City of Hope Comprehensive Cancer Center, Duarte, California
Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Related Articles
Changing the Conversation: Immunotherapy and Long-Term Survival
Morganna Freeman, DO, FACP
January 10, 2019 | Video Library | Clinical Pearls, Immunotherapy
Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.
The Evolving Field of Treatment Modalities
Morganna Freeman, DO, FACP
January 10, 2019 | Video Library | Clinical Pearls, Immunotherapy
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Is Immunotherapy Appropriate Here?
Morganna Freeman, DO, FACP
January 10, 2019 | Video Library | Clinical Pearls, Immunotherapy
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.

Thank you to our Corporate Sponsors and Alliance Partners!

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • National Alliance Partner

    National Alliance Partner

  • Health System Partner

    Health System Partner

  • Health System Partner

    Health System Partner